Literature DB >> 18669148

Risk stratification [corrected] of Brugada syndrome revisited.

Eyal Nof, Charles Antzelevitch.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18669148      PMCID： PMC2562553     

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  27 in total

Review 1.  Proposed diagnostic criteria for the Brugada syndrome: consensus report.

Authors:  Arthur A M Wilde; Charles Antzelevitch; Martin Borggrefe; Josep Brugada; Ramón Brugada; Pedro Brugada; Domenico Corrado; Richard N W Hauer; Robert S Kass; Koonlawee Nademanee; Silvia G Priori; Jeffrey A Towbin
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

2.  Possible role of epicardial left ventricular programmed stimulation in Brugada syndrome.

Authors:  J Carlsson; A Erdogan; B Schulte; J Neuzner; H F Pitschner
Journal:  Pacing Clin Electrophysiol       Date:  2001-02       Impact factor: 1.976

3.  Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.

Authors:  Yuka Mizusawa; Harumizu Sakurada; Mitsuhiro Nishizaki; Masayasu Hiraoka
Journal:  J Cardiovasc Pharmacol       Date:  2006-03       Impact factor: 3.105

Review 4.  Proposed diagnostic criteria for the Brugada syndrome.

Authors:  A A M Wilde; C Antzelevitch; M Borggrefe; J Brugada; R Brugada; P Brugada; D Corrado; R N W Hauer; R S Kass; K Nademanee; S G Priori; J A Towbin
Journal:  Eur Heart J       Date:  2002-11       Impact factor: 29.983

Review 5.  The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option?

Authors:  Bernard Belhassen; Sami Viskin; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2002-11       Impact factor: 1.976

6.  Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).

Authors:  Raphael Rosso; Aharon Glick; Michael Glikson; Abraham Wagshal; Moshe Swissa; Shimon Rosenhek; Israel Shetboun; Vladimir Khalamizer; Therese Fuchs; Munther Boulos; Michael Geist; Boris Strasberg; Michael Ilan; Bernard Belhassen
Journal:  Isr Med Assoc J       Date:  2008-06       Impact factor: 0.892

Review 7.  Assessing predictors of drug-induced torsade de pointes.

Authors:  Luiz Belardinelli; Charles Antzelevitch; Marc A Vos
Journal:  Trends Pharmacol Sci       Date:  2003-12       Impact factor: 14.819

Review 8.  Atrial fibrillation and Brugada syndrome.

Authors:  Johnson Francis; Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2008-03-25       Impact factor: 24.094

9.  Hydroquinidine therapy in Brugada syndrome.

Authors:  Jean-Sylvain Hermida; Isabelle Denjoy; Jérôme Clerc; Fabrice Extramiana; Geneviève Jarry; Paul Milliez; Pascale Guicheney; Stefania Di Fusco; Jean-Luc Rey; Bruno Cauchemez; Antoine Leenhardt
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

10.  Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome.

Authors:  Pierre Bordachar; Sylvain Reuter; Stephane Garrigue; Xu Caï; Mélèze Hocini; Pierre Jaïs; Michel Haïssaguerre; Jacques Clementy
Journal:  Eur Heart J       Date:  2004-05       Impact factor: 29.983
View more
  2 in total

1.  Genetic testing for long QT syndrome and the category of cardiac ion channelopathies.

Authors:  Stephen M Modell; David J Bradley; Michael H Lehmann
Journal:  PLoS Curr       Date:  2012-05-03

Review 2.  Risk factors for cardiac events in patients with Brugada syndrome: A PRISMA-compliant meta-analysis and systematic review.

Authors:  Wenqing Wu; Li Tian; Jinshan Ke; Yi Sun; Ruixia Wu; Jianfang Zhu; Qinmei Ke
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.